argenx SE 2025 Annual Report with Sustainability Disclosures
Company: argenx SE
Sector: Manufacturing
Country: Netherlands
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 336
The report describes argenx's 2025 commercial expansion, with VYVGART product net sales reaching $4.2 billion and the prefilled syringe launching in the U.S., EU and Japan. It reports 1,863 employees and a global pipeline of 10 ongoing registrational trials. The sustainability statement is prepared in accordance with ESRS, covers the full consolidation scope, and includes Scope 1, 2 and 3 emissions. argenx also reports a refreshed double materiality assessment and limited assurance by EY.
Services
From bulk PDFs to structured indicators and machine-readable documents.